BioSpace - Cytogen Corporation News, Search Jobs, Events
16 Oct 2002 ... Cytogen Corporation is a biopharmaceutical company with an established ... exclusively licensed from Memorial Sloan-Kettering Cancer Center. ...
http://www.biospace.com/company_profile.aspx?CompanyId=1356...
|
Cytogen Corporation 22-Sep-99 - DETAIL
... Company Name, Issuing Office, Subject. 09/22/1999, Cytogen Corporation, Center for Biologics Evaluation and Research, OncoScint & ProstaScint ...
http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/1...
|
YAC/BAC FISH Mapping Resource (MCN Reference Center)
In collaboration with the Mendelian Cytogenetic Network (MCN, coordinator:N. Tommerup, Copenhagen http://www.mcndb.imbg.ku.dk) we develop a valuable tool ...
http://www.molgen.mpg.de/~cytogen/...
|
EUSA Pharma to Acquire US Specialty Oncology Company Cytogen ...
11 Mar 2008 ... EVENT CENTER ... The acquisition of Cytogen brings to the enlarged EUSA group an established US commercial ... Upon completion, EUSA intends to apply to delist
all Cytogen's issued shares from the NASDAQ stock exchange. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=88816...
|
Prostate cancer and prostate bed SPECT imaging with ProstaScint ...
Department of Radiology, MetroHealth Medical Center/Case Western Reserve University, Cleveland, Ohio, USA. BACKGROUND: ProstaScint (Cytogen Corporation,
...
http://www.ncbi.nlm.nih.gov/pubmed/9792131...
|
Cytogen Corporation Acquires North American Marketing Rights To ...
11 Oct 2006 ... EVENT CENTER ... "With the addition of CAPHOSOL, Cytogen will have four marketed oncology products. ... The transaction also provides Cytogen with the option to
acquire the rights to CAPHOSOL for the European and Asian ...
http://www.biospace.com/news_story.aspx?NewsEntityId=32888...
|
2005
3 Sep 2009 ... July 01, 2005, Cytogen Corporation, Center for Drug Evaluation and Research, Labeling/Promotional Claims False & Misleading/Misbranded ...
http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2...
|
Cytogen Corporation Release: Prostate-Specific Membrane Antigen ...
EVENT CENTER .... Cytogen is also developing CYT-500, a therapeutic product candidate using ... Cytogen expects to begin the first U.S. Phase I clinical
trial of CYT-500 in patients with hormone-refractory prostate cancer during 2006
. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=19364...
|
VioQuest Appoints Michael D. Becker as President and Chief ...
... download archived video content distributed by MultiVu on The Digital Center . ... Mr. Becker joins VioQuest from Cytogen Corporation, where he served as ...
http://www.prnewswire.com/news-releases/vioquest-appoints-mi...
|
Cytogen Corporation Reports Publication Validating the Utility of ...
PRINCETON, N.J.--(BUSINESS WIRE)--Cytogen Corporation (NASDAQ: CYTO) today reported the publication of a review validating the utility of its ProChart™ ...
http://www.biospace.com/news_story.aspx?NewsEntityId=57502...
|
